Showing 3,801 - 3,820 results of 105,667 for search '(( 50 ((we decrease) OR (mean decrease)) ) OR ( 5 ((ng decrease) OR (a decrease)) ))', query time: 1.17s Refine Results
  1. 3801
  2. 3802
  3. 3803
  4. 3804

    A phenotype of increased sleepiness in a mouse model of pulmonary hypertension and right ventricular hypertrophy by Eric M. Davis (1733638)

    Published 2018
    “…After PAB, mice spent significantly more time in NREM sleep compared to the control group over a 24 hour period (53.5 ± 1.5% vs. 46.6 ± 1.4%; p < 0.01) and exhibited an inability to both cycle into REM sleep and decrease delta density across the light/sleep period. …”
  5. 3805
  6. 3806
  7. 3807
  8. 3808
  9. 3809

    Lifetime risk of developing type 2 diabetes, for cohorts of 25 years-old individuals according to scenarios. by Pierre Bauvin (18154818)

    Published 2024
    “…<p>Initial weight distribution is representative of the one of the 25 years-old individuals in 2022: A) men, 73.2% normal weight, 17.9% overweight, 6.6% obese class I, 1.9% obese class II, 0.5% obese class III, and B) women, 81.0% normal weight, 9.7% overweight, 5.4% obese class I, 2.6% obese class II, 1.3% obese class III. …”
  10. 3810

    Markov model states and transition. by Pierre Bauvin (18154818)

    Published 2024
    “…Only the prevalence of obesity III shows early change able to predict the outcome of a strategy: for example, 6.7%-decrease at one year, 13.3%-decrease at two years with scenario 1 stabilizing obesity at 5 years.…”
  11. 3811
  12. 3812
  13. 3813

    Discovery of Novel Substituted <i>N</i>‑(4-Amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide Analogues as Potent Human Adenovirus Inhibitors by Jimin Xu (2208961)

    Published 2020
    “…We herein reported a series of novel substituted <i>N</i>-(4-amino-2-chlorophenyl)-5-chloro-2-hydroxybenzamide analogues as potent HAdV inhibitors. …”
  14. 3814
  15. 3815
  16. 3816
  17. 3817

    Models for changes in DNA methylation of the <i>WNT5A</i> promoter B region during progression of osteoblast cells to osteosarcoma. by Himani Vaidya (3179403)

    Published 2016
    “…B) NCBI Epigenomics search for CTCF binding in the <i>WNT5A</i> genomic region of human osteoblasts. Location of the CpG regions R3, R4, and R5 are indicated, along with promoter A exon 1 (box) and promoter B exon 1β (box at arrow). …”
  18. 3818

    Inactivation of the <i>WNT5A</i> Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2 by Himani Vaidya (3179403)

    Published 2016
    “…<div><p><i>WNT5A</i> is a secreted ligand involved in Wnt pathway signaling and has a role in cell movement and differentiation. …”
  19. 3819
  20. 3820